SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
Abstract Background Spi-1 proto-oncogene (SPI1), which encodes an ETS-domain transcription factor, can activate gene expression in myeloid and lymphoid lineages. The role of SPI1 in the tumor immune microenvironment in clear cell renal cell carcinoma (ccRCC) remains unknown. In this study, we invest...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer
2022-12-01
|
| 叢編: | Discover Oncology |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1007/s12672-022-00592-0 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|